Skip to Content
Merck
  • Acidic fibroblast growth factor prevents death of spinal cord motoneurons in newborn rats after nerve section.

Acidic fibroblast growth factor prevents death of spinal cord motoneurons in newborn rats after nerve section.

Neurological research (1995-10-01)
P Cuevas, F Carceller, G Giménez-Gallego
ABSTRACT

The death of spinal axotomised motoneurons provides a useful tool for studying neurotrophic factors which could prevent motoneuron loss in vivo. Median and ulnar nerves of newborn rats were unilaterally sectioned and topically treated with either a vehicle solution or acidic fibroblast growth factor (aFGF). aFGF treatment increased the survival of the median and ulnar spinal motoneurons, after 7 days of axotomy, from 37% to 63%. These results show that aFGF is a neurotrophic factor for newborn spinal motoneurons, and suggest that this protein is a potential therapeutic agent for preventing the death of damaged motoneurons.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
FGF-2 human, recombinant, expressed in insect cells, ≥85% (SDS-PAGE)
Sigma-Aldrich
FGF-1 human, recombinant, expressed in insect cells, ≥85% (SDS-PAGE)